Challenges in developing Geroscience trials
Проблемы разработки клинических исследований в области геронауки
2023-08-19
SCID: 54.1/9pv6g6gh
Discuss with AI
GerodiagnosticsGeroscience trialsGerotherapeutic interventionsage-related biomarkersage-related diseases
Figures from the paper
Abstract (AI)
Geroscience is becoming a major hope for preventing age-related diseases and loss of function by targeting biological mechanisms of aging. This unprecedented paradigm shift requires optimizing the design of future clinical studies related to aging in humans. Researchers will face a number of challenges, including ideal populations to study, which lifestyle and Gerotherapeutic interventions to test initially, selecting key primary and secondary outcomes of such clinical trials, and which age-related biomarkers are most valuable for both selecting interventions and predicting or monitoring clinical responses ("Gerodiagnostics"). This article reports the main results of a Task Force of experts in Geroscience.
Key Findings
1
An expert Geroscience Task Force synthesized the field’s main challenges for developing human clinical trials and gerodiagnostics.
2
Clinical geroscience trials require optimized designs tailored to aging-related interventions and outcomes.
3
Geroscience aims to prevent age-related diseases and functional decline by targeting biological mechanisms of aging.
4
Major unresolved challenges include selecting appropriate study populations and prioritizing lifestyle or gerotherapeutic interventions for initial testing.
5
Trials must identify meaningful primary and secondary outcomes, including biomarkers that can select interventions and predict or monitor clinical responses.
Research Object
human clinical trials of aging-related interventions
Research Subject
optimization challenges involving study populations, interventions, clinical outcomes, and age-related biomarkers for preventing age-related diseases and functional loss
Publication Details
Publication Date
2023-08-19
Journal
Publisher
ISSN
Cited by
94
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002
The World Health Organization (WHO) approach to healthy ageing2020
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity2015
Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience2019